関連する実験動画
Updated: Aug 29, 2026
07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
臨床前の心不全における神経経活性化. リモジリングと介入の可能性
G S Francis1, K M McDonald, J N Cohn
1Department of Medicine, University of Minnesota Medical School, Minneapolis.
Circulation
|May 1, 1993
まとめ
臨床前の心不全は,神経内分泌の活性化と左心室機能障害を含む. アンジオテンシン変換酵素阻害剤は,心臓の改造を阻害し,心不全の進行を防ぐための潜在的な治療目標を提供します.
科学分野:
- 心臓病学 心臓病学
- 生理学 生理学とは
- 病理学 パトロジー
背景:
- 閉塞性心不全 (CHF) は,症状のない神経内分泌の活性化と左心室 (LV) 機能不全の臨床前段階をしばしば続きます.
- 心筋損傷は,交感性神経系の活性化,LV高縮,およびLV容量の増加と関連しています.
- 損傷のない心臓組織は,アンジオテンシンゲンのmRNAとアンジオテンシン変換酵素の活性が増加し,細胞成長におけるアンジオテンシンIIの役割を示唆しています.
研究 の 目的:
- 臨床前の心不全における神経内分泌活性化,LV機能不全,心臓リモデリングの相互関係を調査する.
- 犬のモデルで急性心筋損傷後の心臓の形態学的および機能的変化を調査する.
- 血管新生変換酵素 (ACE) 阻害剤が心臓の改造に及ぼす効果を評価する.
主な方法:
- 急性心筋損傷を誘発するために犬のモデルを使用しました.
- 心筋損傷後の左心室の質量,体積,機能の変化をモニタリングする.
- 交感神経系の活性化と神経内分泌マーカーを評価した.
- ACE阻害剤を投与し,心臓の改造に与える影響を評価する.
主要な成果:
- 左心室質量の増加は,心筋損傷に対する最初の反応であり,1週間以内に観察されました.
- 漸進的な交感神経系の活性化,LVの膨張,そして軽度のLV機能不全が続いた.
- LV質量と体積の増加を含む心臓の改造は,ACE阻害剤によって著しく減少しました.
結論:
- 急性心筋損傷は,前臨床性心不全を模倣する一連のイベントを開始し,LVリフォームと神経内分泌の活性化を含む.
- ACE阻害は,心不全の臨床前段階で有害な改造プロセスを阻害する可能性を示しています.
- レニン-アニオテンシン系をターゲットにすることは,明白な充血性心不全への進行を防ぐために有効な戦略である可能性があります.
関連する概念動画
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...